The limitation of this study is that we did not simultaneously test the leptin expression using immunohistochemistry in the pancreatic cancer tissues due to the secretory nature of leptin, which makes quantitative analysis a challenge. This evidence concerns the gene LEP and pancreatic neoplasm.